|
Market Closed -
Boerse Muenchen
16:43:26 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 83.55 EUR | +0.66% |
|
-6.16% | +2.09% |
| 09-11 | Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing | MT |
| 09-10 | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
Company Valuation: BioNTech SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 54,749 | 34,159 | 22,698 | 26,387 | 19,497 | 20,936 | - | - |
| Change | - | -37.61% | -33.55% | 16.25% | -26.11% | 7.38% | - | - |
| Enterprise Value (EV) 1 | 53,358 | 20,496 | 11,253 | 16,879 | 12,356 | 9,567 | 10,905 | 11,497 |
| Change | - | -61.59% | -45.1% | 50% | -26.8% | -22.57% | 13.98% | 5.43% |
| P/E | 5.72x | 3.72x | 24.9x | -39.7x | -17.3x | -14.6x | -15.3x | -21.5x |
| PBR | 4.62x | 1.7x | 1.12x | - | 1.06x | 1.2x | 1.29x | 1.38x |
| PEG | - | -0.79x | -0.3x | 0x | -0.2x | -0.7x | 3.47x | 0.7x |
| Capitalization / Revenue | 2.89x | 1.97x | 5.94x | 9.59x | 6.79x | 11.6x | 11.5x | 9.11x |
| EV / Revenue | 2.81x | 1.18x | 2.95x | 6.14x | 4.31x | 5.3x | 6.01x | 5.01x |
| EV / EBITDA | 3.47x | 1.61x | 12.9x | -16.6x | -12.1x | -6.66x | -7.47x | -10.7x |
| EV / EBIT | 3.49x | 1.62x | 16.3x | -12.8x | -8.79x | -5.25x | -6.41x | -9.42x |
| EV / FCF | 72.5x | 1.55x | 2.41x | -69x | 44x | -5.48x | -5.61x | -6.72x |
| FCF Yield | 1.38% | 64.5% | 41.5% | -1.45% | 2.27% | -18.2% | -17.8% | -14.9% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 39.63 | 37.77 | 3.83 | -2.77 | -4.7 | -5.698 | -5.447 | -3.87 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18,977 | 17,311 | 3,819 | 2,751 | 2,870 | 1,807 | 1,813 | 2,297 |
| EBITDA 1 | 15,359 | 12,766 | 873.8 | -1,016 | -1,022 | -1,437 | -1,459 | -1,076 |
| EBIT 1 | 15,284 | 12,643 | 690.4 | -1,314 | -1,405 | -1,822 | -1,701 | -1,220 |
| Net income 1 | 10,292 | 9,434 | 930.3 | -665.3 | -1,136 | -1,378 | -1,309 | -953.2 |
| Net Debt 1 | -1,391 | -13,663 | -11,445 | -9,508 | -7,141 | -11,369 | -10,031 | -9,439 |
| Reference price 2 | 226.68 | 140.56 | 95.48 | 110.06 | 81.08 | 83.34 | 83.34 | 83.34 |
| Nbr of stocks (in thousands) | 241,521 | 243,019 | 237,716 | 239,740 | 240,455 | 251,204 | - | - |
| Announcement Date | 3/30/22 | 3/27/23 | 3/20/24 | 3/10/25 | 3/10/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.07x | 7.08x | 14.22x | 1.48% | 68.24B | |
| 32.07x | 9.28x | 44.74x | 0.04% | 62.23B | |
| -77.91x | 15.04x | -72.53x | -.--% | 27.8B | |
| 28.78x | 6.1x | 15.83x | -.--% | 24.86B | |
| -14.55x | 5.23x | -6.58x | -.--% | 24.22B | |
| 26.34x | 4.96x | 16.5x | -.--% | 19.36B | |
| 49.79x | 18.37x | 37.27x | 0.3% | 17.28B | |
| 1249.7x | 36.02x | 786.01x | -.--% | 14.46B | |
| 17.74x | 5.28x | 12.34x | -.--% | 14.23B | |
| Average | 148.00x | 11.93x | 94.20x | 0.2% | 30.3B | |
| Weighted average by Cap. | 77.96x | 10.15x | 53.10x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
- Valuation BioNTech SE
Select your edition
All financial news and data tailored to specific country editions
